Last reviewed · How we verify
ABBV-CLS-484
At a glance
| Generic name | ABBV-CLS-484 |
|---|---|
| Sponsor | Calico Life Sciences LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors (PHASE1)
- Expanded Access to ABBV-CLS-484
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |